Xoma reported $-4178000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agenus AGEN:US USD -56715000 7.48M
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Ardelyx ARDX:US USD -22893000 4.04M
Bluebird Bio BLUE:US USD -76513000 16.99M
Celldex Therapeutics CLDX:US USD -26784000 546K
Chimerix CMRX:US USD 241.52M 264.98M
Curis CRIS:US USD -13294000 2.65M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
Life Technologies LIFE:US USD -13245000 824K
Macrogenics MGNX:US USD -24813000 16.49M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Prothena PRTA:US USD -48417000 5.84M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Teva Pharmaceutical Industries TEVA:US USD 769M 62M
Xoma XOMA:US USD -4178000 492K
YTE INCY:US USD 178.22M 131.36M